Germinated Waxy Black Rice Ameliorates Hyperglycemia and Dyslipidemia in Streptozotocin-Induced Diabetic Rats

Biol Pharm Bull. 2017;40(11):1846-1855. doi: 10.1248/bpb.b17-00239.

Abstract

This study aimed to examine the anti-diabetic effect of germinated waxy black rice (GWBR) using streptozotocin (STZ)-induced diabetic rats. In the diabetic rats, GWBR supplementation for 8 weeks reduced plasma blood glucose concentrations, improved glucose clearance and prevented diabetes-induced weight loss. Rats with STZ-induced diabetes who received GWBR supplementation exhibited decreased expression of sodium-dependent glucose transporter 1 (SGLT1) and glucose transporter (GLUT) 2 genes and proteins in the small intestine via decreases in hepatocyte nuclear factor (HNF)-1α, HNF-1β, and HNF-4α, transcriptional factors that are involved in the regulation of SGLT1 and GLUT2, compared with the rats with STZ-induced diabetes that did not receive GWBR supplements. GWBR supplementation also enhanced the expression of GLUT4 and the genes and proteins involved in GLUT4 translocation, such as insulin receptor (IR) and insulin receptor substrate 1 (IRS1), and increased the phosphorylation of phosphoinositide 3-kinase (PI3K) and protein kinase B (PKB, Akt) proteins in skeletal muscle. GWBR further increased glycogen synthase (GS) 1 by decreasing glycogen synthase kinase (GSK)-3β in skeletal muscle. Interestingly, GWBR recovered STZ-impaired pancreatic β-cells, resulting in increased insulin synthesis and secretion. In addition, GWBR reduced serum triglyceride, total cholesterol, low-density lipoprotein cholesterol, aspartate transferase and alanine transferase concentrations and increased high-density lipoprotein cholesterol concentrations. Taken together, these findings suggest that GWBR could be a candidate for improving the diabetic condition by regulating glucose uptake in the intestine and muscle and regulating the secretion of insulin from the pancreas.

Keywords: anti-diabete; germinated waxy black rice; glucose uptake; streptozotocin-induced diabetic rat.

MeSH terms

  • Animals
  • Blood Glucose
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / diet therapy*
  • Dyslipidemias / blood
  • Dyslipidemias / diet therapy*
  • Germination
  • Glucose / metabolism*
  • Glucose Transporter Type 4 / metabolism
  • Hepatocyte Nuclear Factors / metabolism
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / diet therapy*
  • Insulin / metabolism*
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Secretion
  • Insulin-Secreting Cells / enzymology
  • Insulin-Secreting Cells / metabolism
  • Intestine, Small / enzymology
  • Intestine, Small / metabolism
  • Lipids / blood
  • Male
  • Muscle, Skeletal / enzymology
  • Muscle, Skeletal / metabolism
  • Oryza / chemistry*
  • Oryza / growth & development
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Insulin / metabolism
  • Sodium-Glucose Transporter 1 / metabolism
  • Streptozocin / toxicity

Substances

  • Blood Glucose
  • Glucose Transporter Type 4
  • Hepatocyte Nuclear Factors
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Lipids
  • Slc2a4 protein, rat
  • Slc5a1 protein, rat
  • Sodium-Glucose Transporter 1
  • Streptozocin
  • Receptor, Insulin
  • Glucose